JPS58185562A - １，４−ジヒドロピリジン誘導体 - Google Patents

１，４−ジヒドロピリジン誘導体

Info

Publication number
JPS58185562A
JPS58185562A JP57067759A JP6775982A JPS58185562A JP S58185562 A JPS58185562 A JP S58185562A JP 57067759 A JP57067759 A JP 57067759A JP 6775982 A JP6775982 A JP 6775982A JP S58185562 A JPS58185562 A JP S58185562A
Authority
JP
Japan
Prior art keywords
ester
acid
nidoradoethyl
group
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57067759A
Other languages
English (en)
Japanese (ja)
Other versions
JPS635024B2 (enExample
Inventor
Katsuo Hatayama
畑山　勝男
Atsuo Nakazato
篤郎 中里
Toshihisa Ogawa
小川　利寿
Shoichi Ito
正一 伊藤
Jiro Sawada
沢田　二郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP57067759A priority Critical patent/JPS58185562A/ja
Priority to EP83302075A priority patent/EP0092936B1/en
Priority to DE8383302075T priority patent/DE3370620D1/de
Priority to US06/486,508 priority patent/US4472411A/en
Priority to SE8305467A priority patent/SE440648B/sv
Priority to AU19941/83A priority patent/AU565424B2/en
Priority to BE0/211728A priority patent/BE898024A/fr
Priority to NL8303616A priority patent/NL8303616A/nl
Publication of JPS58185562A publication Critical patent/JPS58185562A/ja
Publication of JPS635024B2 publication Critical patent/JPS635024B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP57067759A 1982-04-22 1982-04-22 １，４−ジヒドロピリジン誘導体 Granted JPS58185562A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP57067759A JPS58185562A (ja) 1982-04-22 1982-04-22 １，４−ジヒドロピリジン誘導体
EP83302075A EP0092936B1 (en) 1982-04-22 1983-04-13 1,4-dihydropyridine derivatives
DE8383302075T DE3370620D1 (en) 1982-04-22 1983-04-13 1,4-dihydropyridine derivatives
US06/486,508 US4472411A (en) 1982-04-22 1983-04-19 1,4-Dihydropyridine derivatives and use as vasodilators
SE8305467A SE440648B (sv) 1982-04-22 1983-10-05 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar
AU19941/83A AU565424B2 (en) 1982-04-22 1983-10-06 2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters
BE0/211728A BE898024A (fr) 1982-04-22 1983-10-19 Derives de 1,4-dihydropyridine et compositions pharmaceutiques a action vasodilatatrice les contenant.
NL8303616A NL8303616A (nl) 1982-04-22 1983-10-20 1,4-dihydropyridinederivaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57067759A JPS58185562A (ja) 1982-04-22 1982-04-22 １，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
JPS58185562A true JPS58185562A (ja) 1983-10-29
JPS635024B2 JPS635024B2 (enExample) 1988-02-01

Family

ID=13354183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57067759A Granted JPS58185562A (ja) 1982-04-22 1982-04-22 １，４−ジヒドロピリジン誘導体

Country Status (8)

Country Link
US (1) US4472411A (enExample)
EP (1) EP0092936B1 (enExample)
JP (1) JPS58185562A (enExample)
AU (1) AU565424B2 (enExample)
BE (1) BE898024A (enExample)
DE (1) DE3370620D1 (enExample)
NL (1) NL8303616A (enExample)
SE (1) SE440648B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59110671A (ja) * 1982-11-30 1984-06-26 バイエル・アクチエンゲゼルシヤフト １，４−ジヒドロピリジン誘導体
EP0207674A2 (en) 1985-06-14 1987-01-07 Sankyo Company Limited 1,4-Dihydropyridine derivatives, their preparation and their pharmaceutical use
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127150A3 (en) * 1983-05-27 1987-07-22 Fujisawa Pharmaceutical Co., Ltd. 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4730052A (en) * 1984-07-13 1988-03-08 Taisho Pharmaceutical Co., Ltd. Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk ３−アミノカルボニル−１，４−ジヒドロピリジン−５−カルボン酸誘導体、その製法および医薬組成物
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
BRPI1011188B1 (pt) 2009-05-06 2019-10-15 Laboratory Skin Care, Inc. Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59110671A (ja) * 1982-11-30 1984-06-26 バイエル・アクチエンゲゼルシヤフト １，４−ジヒドロピリジン誘導体
EP0207674A2 (en) 1985-06-14 1987-01-07 Sankyo Company Limited 1,4-Dihydropyridine derivatives, their preparation and their pharmaceutical use
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
SE440648B (sv) 1985-08-12
US4472411A (en) 1984-09-18
AU565424B2 (en) 1987-09-17
EP0092936B1 (en) 1987-04-01
BE898024A (fr) 1984-04-19
EP0092936A1 (en) 1983-11-02
DE3370620D1 (en) 1987-05-07
JPS635024B2 (enExample) 1988-02-01
SE8305467D0 (sv) 1983-10-05
SE8305467L (sv) 1985-04-06
NL8303616A (nl) 1985-05-17
AU1994183A (en) 1985-04-18

Similar Documents

Publication Publication Date Title
JPS58185562A (ja) １，４−ジヒドロピリジン誘導体
US4672068A (en) Antihypertensive 1,4-dihydropyridines having a conjugated ester
US5856346A (en) Short-acting dihydropyridines
JPS61152662A (ja) 新規な二環式複素アリールピペラジン化合物とその医薬並びにその製造法
JP2022515755A (ja) 網膜疾患用化合物
JP4659214B2 (ja) イソソルビドモノニトレートの誘導体及び耐性が低下した血管拡張剤としてのその使用
CH655110A5 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
JPH02152963A (ja) ４―フェニル―４―〔ｎ―（フェニル）アミド〕ピペリジン誘導体及びこの誘導体を含む製剤組成物
JPS6287574A (ja) 新規なｎ置換３，４−ジヒドロピリミジン−２−オン誘導体、その製造法及び循環器系疾患治療剤
JPS6048970A (ja) ジヒドロピリジン誘導体
JPS63225354A (ja) アゼチジノン誘導体
WO1994012493A1 (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
US4732898A (en) 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
JPS62167764A (ja) メチオニン−置換１，４−ジヒドロピリジン類
JPS59106462A (ja) 強心剤として有用な２（１ｈ）−ピリジノン類およびその製造方法
JPS6147477A (ja) 新規１，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
KR890001699B1 (ko) 1,4-디하이드로피리딘 유도체의 제조 방법
JPS59186977A (ja) 気管支分泌促進作用を有するチオ乳酸誘導体及びその製法
US5286869A (en) 1,4-dihydropyridine derivatives
SK47794A3 (en) Chinolyl-dihydropyridinecarboxylic acid esters, method of their production, medicines containing these matters, method of their production and using of these compounds
JPH02138257A (ja) １，４―ジヒドロピリジン化合物
JPS6110576A (ja) 新規な１，４―ジヒドロピリジン誘導体およびその塩、それらの製造法並びにそれらを含有する循環障害治療剤
JPS61251661A (ja) １，４−ジヒドロピリジン誘導体
JPH02288876A (ja) 新規な世代の１，４―ジヒドロピリジン誘導体